RxDoctor Payments DataLook up a doctor →

Michael Ament

Neurology · Denver, CONPI 1437111010

Payments from drug & device makers

$457,389in general payments, 2019–2025

Across 805 payments — averaging $568.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$191K
  • AbbVie$126K
  • Biohaven Pharmaceutical Holding Company Ltd.$42K
  • Teva Pharmaceuticals USA, Inc.$38K
  • Biohaven Pharmaceuticals, Inc.$27K
  • Amgen$16K
  • plus $17K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$457,389 in reported general payments places this provider in the 90th percentile of 334 neurology providers in Colorado.

See all neurology providers in Colorado

Other neurology in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →